A great deal of evidence has confirmed the roles of interleukins [3] or chemokines, especially the CXCL8-CXCR1/2 axis, in proinflammation, tumor enhancement, and immunotherapy resistance [4]. The gene discussed is CXCR1; the disease is neoplasm.